[31 May 2019] The IBTA’s monthly e-News has now been released and been emailed to all subscribers. Some of the highlights from this month include news that Giolan has been rolled out as part of the NHS Long Term Plan …
Read More
[27 May 2019] NCI-CONNECT has established a national network of centers willing and eager to participate in studying rare brain and spine tumours…
Copies of the 2019/20 world edition of our “Brain Tumour” magazine have been landing in the letterboxes of subscribers in over 111 countries across the globe, free of charge.
[8 March 2019] The EORTC has published a landmark manifesto, which sets an international framework for research into personalised cancer therapies and calls for reforming the current system to a truly ‘patient centred’ approach…
[10 January 2019] The IBTA is delighted to announce that the next International Brain Tumour Awareness Week will be taking place from Saturday, 26 October to Saturday, 2 November 2019 inclusive. Now in its thirteenth year…
The All.Can initiative has presented the first findings of its UK patient survey at a UK Parliamentary event. They showed that 36% of people considered the cancer diagnosis stage as the biggest cause of inefficiency in their care. Two in five people with cancer had been initially misdiagnosed with something else – sometimes on multiple occasions – and one in five had to wait more than six months for a cancer diagnosis.
The findings were presented at the Britain Against Cancer conference, hosted by the All-Party Parliamentary Group on Cancer. The event took place on 4 December at the UK Parliament in London. The UK national initiative is the first of nine countries to release findings from the All.Can patient survey, which sought patients’ and carers’ perspectives on inefficiencies in cancer care.
All.Can is an international multi-stakeholder policy initiative that is focused on improving efficiency in cancer care, in which the IBTA is one of the stakeholder organisations. The UK national initiative is the first of nine countries to release findings from the All.Can patient survey. A report of the findings from all countries is due to be published in early 2019. Read more.
